Analystreport

ProQR Therapeutics (NASDAQ: PRQR) was upgraded by analysts at JMP Securities from a "market perform" rating to an "outperform" rating.

ProQR Therapeutics N.V. - Ordinary Shares  (PRQR) 
Last proqr therapeutics n.v. - ordinary shares earnings: 2/26 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: proqr.com